Interleukin-8-induced CSC development in colon and lung cancer cells relies on GFPT1-mediated O-GlcNAc modifications, demonstrating the critical involvement of the HBP pathway in cancer stemness [144]. The gene discussed is GFPT1; the disease is lung cancer.